In a third study, Rad9 acted as a corepressor of AR transactivation [74]—all of which suggest that Rad9 expression may be a significant part of the “androgen switch” that leads to cancer cell survival and that Rad9 has functions beyond DNA repair that make it clinically relevant as a biomarker or in tumor growth control [72]. The gene discussed is RAD9A; the disease is neoplasm.